Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0fc810249d5eac08e81def7e1a0b6d44 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-506 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0053 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2018 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2813 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-282 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2826 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2866 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-506 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00 |
filingDate |
2020-12-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2022-05-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_91ea430ad5110797a31937c6b2627620 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a875ebc7b57511295e43ae9b60fc99df http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_053c31a80ed9a4b57ba29144f49103b3 |
publicationDate |
2022-05-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-11344500-B2 |
titleOfInvention |
Rapidly disintegrating solid oral dosage forms containing dasatinib |
abstract |
The instant application relates to the field of pharmaceutical compositions comprising dasatinb. Furthermore, the instant application relates to a method of treating proliferative disorders in a patient in need thereof, comprising administering a therapeutically effective amount of said compositions. |
priorityDate |
2019-05-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |